company background image
PRPH logo

ProPhase Labs NasdaqCM:PRPH Stok Raporu

Son Fiyat

US$2.14

Piyasa Değeri

US$40.8m

7D

-10.8%

1Y

-53.3%

Güncellenmiş

04 Nov, 2024

Veri

Şirket Finansalları +

ProPhase Labs, Inc.

NasdaqCM:PRPH Stok Raporu

Piyasa değeri: US$40.8m

PRPH Stoklara Genel Bakış

ProPhase Labs, Inc. Amerika Birleşik Devletleri'nde yeni ilaçlar, diyet takviyeleri ve bileşikler geliştirmekte ve ticarileştirmektedir.

ProPhase Labs, Inc. Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti ProPhase Labs
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıUS$2.14
52 Haftanın En Yüksek SeviyesiUS$7.48
52 Haftanın En Düşük SeviyesiUS$2.00
Beta-0.11
11 Aylık Değişim-13.01%
3 Aylık Değişim-21.61%
1 Yıllık Değişim-53.28%
33 Yıllık Değişim-63.54%
5 Yıllık Değişim6.47%
Halka arzdan bu yana değişim328.00%

Son Haberler & Güncellemeler

Market Cool On ProPhase Labs, Inc.'s (NASDAQ:PRPH) Revenues Pushing Shares 26% Lower

Jul 03
Market Cool On ProPhase Labs, Inc.'s (NASDAQ:PRPH) Revenues Pushing Shares 26% Lower

Recent updates

Market Cool On ProPhase Labs, Inc.'s (NASDAQ:PRPH) Revenues Pushing Shares 26% Lower

Jul 03
Market Cool On ProPhase Labs, Inc.'s (NASDAQ:PRPH) Revenues Pushing Shares 26% Lower

Does This Valuation Of ProPhase Labs, Inc. (NASDAQ:PRPH) Imply Investors Are Overpaying?

Mar 04
Does This Valuation Of ProPhase Labs, Inc. (NASDAQ:PRPH) Imply Investors Are Overpaying?

ProPhase Labs, Inc.'s (NASDAQ:PRPH) Business And Shares Still Trailing The Industry

Jan 09
ProPhase Labs, Inc.'s (NASDAQ:PRPH) Business And Shares Still Trailing The Industry

ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 28% Above Their Intrinsic Value Estimate

Sep 21
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 28% Above Their Intrinsic Value Estimate

Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt

Aug 11
Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt

We Ran A Stock Scan For Earnings Growth And ProPhase Labs (NASDAQ:PRPH) Passed With Ease

Apr 07
We Ran A Stock Scan For Earnings Growth And ProPhase Labs (NASDAQ:PRPH) Passed With Ease

ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly

Jan 24
ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly

ProPhase Labs: Small Cap Stock With Strong Fundamentals And Growth Potential

Oct 13

ProPhase Labs Q2 2022 Earnings Preview

Aug 10

We Think ProPhase Labs (NASDAQ:PRPH) Can Stay On Top Of Its Debt

Jul 26
We Think ProPhase Labs (NASDAQ:PRPH) Can Stay On Top Of Its Debt

ProPhase Labs to license two investigational cancer compounds from Global BioLife

Jul 21

ProPhase Labs: A Stellar Quarter And Another Special Dividend

May 16

ProPhase Labs (NASDAQ:PRPH) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Apr 08
ProPhase Labs (NASDAQ:PRPH) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

ProPhase Labs (NASDAQ:PRPH) Is Using Debt Safely

Mar 23
ProPhase Labs (NASDAQ:PRPH) Is Using Debt Safely

Rock star Growth Puts ProPhase Labs (NASDAQ:PRPH) In A Position To Use Debt

Nov 30
Rock star Growth Puts ProPhase Labs (NASDAQ:PRPH) In A Position To Use Debt

As Employer Vaccine Mandates Fail, Prophase Labs Could Benefit

Oct 20

Calculating The Fair Value Of ProPhase Labs, Inc. (NASDAQ:PRPH)

Jul 22
Calculating The Fair Value Of ProPhase Labs, Inc. (NASDAQ:PRPH)

ProPhase Labs Is A Potential Pure Play On Worries About The Delta And Delta Plus Covid-19 Variants

Jun 28

Here's Why Shareholders May Consider Paying ProPhase Labs, Inc.'s (NASDAQ:PRPH) CEO A Little More

May 14
Here's Why Shareholders May Consider Paying ProPhase Labs, Inc.'s (NASDAQ:PRPH) CEO A Little More

ProPhase Labs partners with Dutchess County New York to provide COVID-19 testing

May 06

A Look At The Intrinsic Value Of ProPhase Labs, Inc. (NASDAQ:PRPH)

Apr 12
A Look At The Intrinsic Value Of ProPhase Labs, Inc. (NASDAQ:PRPH)

Hissedar Getirileri

PRPHUS PharmaceuticalsUS Pazar
7D-10.8%-3.7%-1.6%
1Y-53.3%17.2%30.8%

Getiri vs. Endüstri: PRPH underperformed the US Pharmaceuticals industry which returned 17.2% over the past year.

Getiri vs Piyasa: PRPH underperformed the US Market which returned 30.8% over the past year.

Fiyat Oynaklığı

Is PRPH's price volatile compared to industry and market?
PRPH volatility
PRPH Average Weekly Movement12.6%
Pharmaceuticals Industry Average Movement9.3%
Market Average Movement6.0%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.9%

İstikrarlı Hisse Senedi Fiyatı: PRPH's share price has been volatile over the past 3 months compared to the US market.

Zaman İçindeki Volatilite: PRPH's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
1989113Ted Karkuswww.prophaselabs.com

ProPhase Labs, Inc. Amerika Birleşik Devletleri'nde yeni ilaçlar, diyet takviyeleri ve bileşikler geliştirmekte ve ticarileştirmektedir. İki segment üzerinden faaliyet göstermektedir: Teşhis Hizmetleri ve Tüketici Ürünleri. Şirket, erkek cinsel sağlığı için Legendz XL ve bir enerji ve dayanıklılık artırıcı olan Triple Edge XL dahil olmak üzere bir dizi TK takviyesi sunmaktadır.

ProPhase Labs, Inc. Temel Bilgiler Özeti

ProPhase Labs'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
PRPH temel i̇stati̇sti̇kler
Piyasa değeriUS$40.83m
Kazançlar(TTM)-US$26.31m
Gelir(TTM)US$17.97m

2.3x

P/S Oranı

-1.6x

F/K Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
PRPH gelir tablosu (TTM)
GelirUS$17.97m
Gelir MaliyetiUS$19.61m
Brüt Kâr-US$1.64m
Diğer GiderlerUS$24.67m
Kazançlar-US$26.31m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)-1.38
Brüt Marj-9.11%
Net Kâr Marjı-146.39%
Borç/Özkaynak Oranı30.8%

PRPH uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün